Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Alpha- Antitrypsin Deficiency Treatment Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Alpha- Antitrypsin Deficiency Treatment Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.3 USA Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.5 Japan Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.6 Korea Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.7 India Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.8 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Performance
• 2.9 South America Alpha- Antitrypsin Deficiency Treatment Market Performance

3 Global Alpha- Antitrypsin Deficiency Treatment Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.3 USA Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.5 Japan Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.6 Korea Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.7 India Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.8 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)
• 3.9 South America Alpha- Antitrypsin Deficiency Treatment Market Performance (Volume)

4 Competitive Analysis

• 4.1 Adverum Biotechnologies, Inc.
  • 4.1.1 Adverum Biotechnologies, Inc. Profiles
  • 4.1.2 Adverum Biotechnologies, Inc. Product Information
  • 4.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.1.4 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Alnylam Pharmaceuticals, Inc.
  • 4.2.1 Alnylam Pharmaceuticals, Inc. Profiles
  • 4.2.2 Alnylam Pharmaceuticals, Inc. Product Information
  • 4.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.2.4 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Applied Genetic Technologies Corporation
  • 4.3.1 Applied Genetic Technologies Corporation Profiles
  • 4.3.2 Applied Genetic Technologies Corporation Product Information
  • 4.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.3.4 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Arrowhead Pharmaceuticals, Inc.
  • 4.4.1 Arrowhead Pharmaceuticals, Inc. Profiles
  • 4.4.2 Arrowhead Pharmaceuticals, Inc. Product Information
  • 4.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.4.4 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Carolus Therapeutics, Inc.
  • 4.5.1 Carolus Therapeutics, Inc. Profiles
  • 4.5.2 Carolus Therapeutics, Inc. Product Information
  • 4.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.5.4 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Cevec Pharmaceuticals GmbH
  • 4.6.1 Cevec Pharmaceuticals GmbH Profiles
  • 4.6.2 Cevec Pharmaceuticals GmbH Product Information
  • 4.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.6.4 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Dicerna Pharmaceuticals, Inc.
  • 4.7.1 Dicerna Pharmaceuticals, Inc. Profiles
  • 4.7.2 Dicerna Pharmaceuticals, Inc. Product Information
  • 4.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.7.4 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Digna Biotech, S.L.
  • 4.8.1 Digna Biotech, S.L. Profiles
  • 4.8.2 Digna Biotech, S.L. Product Information
  • 4.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.8.4 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Editas Medicine, Inc.
  • 4.9.1 Editas Medicine, Inc. Profiles
  • 4.9.2 Editas Medicine, Inc. Product Information
  • 4.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.9.4 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Grifols, S.A.
  • 4.10.1 Grifols, S.A. Profiles
  • 4.10.2 Grifols, S.A. Product Information
  • 4.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin
  • 4.10.4 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Inhibrx
• 4.12 Intellia Therapeutics, Inc.
• 4.13 International Stem Cell Corporation
• 4.14 Ionis Pharmaceuticals, Inc.
• 4.15 Kamada Ltd.
• 4.16 Polyphor Ltd.
• 4.17 ProMetic Life Sciences Inc.
• 4.18 rEVO Biologics, Inc.
• 4.19 Sangamo BioSciences, Inc.

5 Competitive Landscape

• 5.1 Global Alpha- Antitrypsin Deficiency Treatment Production (K Units) and Market Share by Manufacturers (2014-2019)
• 5.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global Alpha- Antitrypsin Deficiency Treatment Price (USD/Unit) of Manufacturers (2014-2019)
• 5.4 Global Alpha- Antitrypsin Deficiency Treatment Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global Alpha- Antitrypsin Deficiency Treatment Market Assessment by Regions

• 6.1 Global Alpha- Antitrypsin Deficiency Treatment Production (K Units) and Market Share by Regions (2014-2019)
• 6.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global Alpha- Antitrypsin Deficiency Treatment Price (USD/Unit) by Regions (2014-2019)
• 6.4 Global Alpha- Antitrypsin Deficiency Treatment Gross Margin by Regions (2014-2019)

7 Alpha- Antitrypsin Deficiency Treatment Regional Analysis

• 7.1 China Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.6 India Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate (2014-2019)

8 Global Alpha- Antitrypsin Deficiency Treatment Consumption Assessment

• 8.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption and Market Share by Regions (2014-2019)
• 8.2 Global Alpha- Antitrypsin Deficiency Treatment Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global Alpha- Antitrypsin Deficiency Treatment Average Price (USD/Unit) by Regions (2014-2019)

9 Global Alpha- Antitrypsin Deficiency Treatment Sales Assessment by Regions

• 9.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.2 China Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.3 USA Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.4 Europe Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.5 Japan Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.6 Korea Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.7 India Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)
• 9.9 South America Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global Alpha- Antitrypsin Deficiency Treatment Production and Revenue by Regions 2020-2025
  • 12.1.2 China Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China Alpha- Antitrypsin Deficiency Treatment Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America Alpha- Antitrypsin Deficiency Treatment Sales and Sales Value Forecast 2020-2025
• 12.3 Global Alpha- Antitrypsin Deficiency Treatment Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 CT-2009
  • 12.3.3 POL-6014
  • 12.3.4 ARO-AAT
  • 12.3.5 ALNAAT-02
  • 12.3.6 Others
• 12.4 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Clinic
  • 12.4.3 Hospital
  • 12.4.4 Others
• 12.5 Global Alpha- Antitrypsin Deficiency Treatment Price and Gross Margin Forecast
  • 13.5.1 Global Alpha- Antitrypsin Deficiency Treatment Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global Alpha- Antitrypsin Deficiency Treatment Gross Margin Development Trend Forecast 2020-2025

13 Conclusion